361 related articles for article (PubMed ID: 35050660)
1. Nervous system consequences of COVID-19.
Spudich S; Nath A
Science; 2022 Jan; 375(6578):267-269. PubMed ID: 35050660
[TBL] [Abstract][Full Text] [Related]
2. Letter to the Editor: "What Are the Long-Term Neurological and Neuropsychiatric Consequences of COVID-19?".
Pan Y; Zhao S; Chen F
World Neurosurg; 2020 Dec; 144():310-311. PubMed ID: 33227857
[No Abstract] [Full Text] [Related]
3. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms.
Johansson A; Mohamed MS; Moulin TC; Schiöth HB
J Neuroimmunol; 2021 Sep; 358():577658. PubMed ID: 34304141
[TBL] [Abstract][Full Text] [Related]
4. Chronic long-COVID syndrome: A protracted COVID-19 illness with neurological dysfunctions.
Baig AM
CNS Neurosci Ther; 2021 Dec; 27(12):1433-1436. PubMed ID: 34626096
[TBL] [Abstract][Full Text] [Related]
5. Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection.
Llach CD; Vieta E
Eur Neuropsychopharmacol; 2021 Aug; 49():119-121. PubMed ID: 33992951
[No Abstract] [Full Text] [Related]
6. Emerging neurotropic features of SARS-CoV-2.
Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
[TBL] [Abstract][Full Text] [Related]
7. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.
Carod-Artal FJ
Rev Neurol; 2021 Jun; 72(11):384-396. PubMed ID: 34042167
[TBL] [Abstract][Full Text] [Related]
8. A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.
Xu Y; Zhuang Y; Kang L
Med Sci Monit; 2021 Jun; 27():e932962. PubMed ID: 34145211
[TBL] [Abstract][Full Text] [Related]
9. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.
Heming M; Li X; Räuber S; Mausberg AK; Börsch AL; Hartlehnert M; Singhal A; Lu IN; Fleischer M; Szepanowski F; Witzke O; Brenner T; Dittmer U; Yosef N; Kleinschnitz C; Wiendl H; Stettner M; Meyer Zu Hörste G
Immunity; 2021 Jan; 54(1):164-175.e6. PubMed ID: 33382973
[TBL] [Abstract][Full Text] [Related]
10. Neuro-COVID-19: What are we talking about?
El Otmani H; Moutaouakil F
Rev Neurol (Paris); 2020 Sep; 176(7-8):527-528. PubMed ID: 32527470
[No Abstract] [Full Text] [Related]
11. Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms.
Bartley CM; Johns C; Ngo TT; Dandekar R; Loudermilk RL; Alvarenga BD; Hawes IA; Zamecnik CR; Zorn KC; Alexander JR; Wapniarski AE; DeRisi JL; Francisco C; Nash KB; Wietstock SO; Pleasure SJ; Wilson MR
JAMA Neurol; 2021 Dec; 78(12):1503-1509. PubMed ID: 34694339
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.
Jafari Khaljiri H; Jamalkhah M; Amini Harandi A; Pakdaman H; Moradi M; Mowla A
Neurotox Res; 2021 Oct; 39(5):1613-1629. PubMed ID: 34169404
[TBL] [Abstract][Full Text] [Related]
13. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease.
Balcom EF; Nath A; Power C
Brain; 2021 Dec; 144(12):3576-3588. PubMed ID: 34398188
[TBL] [Abstract][Full Text] [Related]
15. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms.
Troyer EA; Kohn JN; Hong S
Brain Behav Immun; 2020 Jul; 87():34-39. PubMed ID: 32298803
[TBL] [Abstract][Full Text] [Related]
16. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses.
Song WJ; Hui CKM; Hull JH; Birring SS; McGarvey L; Mazzone SB; Chung KF
Lancet Respir Med; 2021 May; 9(5):533-544. PubMed ID: 33857435
[TBL] [Abstract][Full Text] [Related]
17. Rogue antibodies could be driving severe COVID-19.
Khamsi R
Nature; 2021 Feb; 590(7844):29-31. PubMed ID: 33469204
[No Abstract] [Full Text] [Related]
18. The link between microglia and the severity of COVID-19: The "two-hit" hypothesis.
Bouayed J; Bohn T
J Med Virol; 2021 Jul; 93(7):4111-4113. PubMed ID: 33788265
[TBL] [Abstract][Full Text] [Related]
19. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
20. [Update 2021: COVID-19 from the perspective of neurology].
Simon OJ; Menzler K; Timmermann L
Dtsch Med Wochenschr; 2021 Jul; 146(13-14):918-923. PubMed ID: 34256409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
